SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

With no major difference for the quarter endedJune 2022 , the total revenue stood at Rs. 946.75  millions.The Net Loss for the quarter ended June 2022 is Rs. -154.37 millions as compared to Net Loss of Rs. -35.68 millions of corresponding quarter ended June 2021The company reported a degrowth in operating Profit to 66.32 millions from 174.19 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 946.75 904.22 4.70 946.75 904.22 4.70 3977.14 3560.59 11.70
Other Income 15.07 67.71 -77.74 15.07 67.71 -77.74 235.45 152.21 54.69
PBIDT 66.32 174.19 -61.93 66.32 174.19 -61.93 688.94 565.95 21.73
Interest 150.63 127.34 18.29 150.63 127.34 18.29 571.59 521.78 9.55
PBDT -84.31 46.85 -279.96 -84.31 46.85 -279.96 124.69 32.10 288.44
Depreciation 70.06 78.35 -10.58 70.06 78.35 -10.58 320.73 327.03 -1.93
PBT -154.37 -31.50 390.06 -154.37 -31.50 390.06 -196.04 -294.93 -33.53
TAX 0.00 4.18 0.00 0.00 4.18 0.00 4.18 3.23 29.41
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -154.37 -35.68 332.65 -154.37 -35.68 332.65 -200.22 -298.16 -32.85
Equity 108.33 108.33 0.00 108.33 108.33 0.00 108.33 108.33 0.00
PBIDTM(%) 7.01 19.26 -63.64 7.01 19.26 -63.64 17.32 15.89 8.98

Ind-Swift - Amalgama Share Price

15.70 0.00 (0.00%)
13-Aug-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×